Navigation Links
Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement
Date:12/14/2009

WALTHAM, Mass., Dec. 14 /PRNewswire-FirstCall/ -- Lionbridge (Nasdaq: LIOX) today announced that it has signed a new, three-year master services agreement with a multi-billion dollar biotech company with products and services that serve patients in approximately 100 countries. With the agreement Lionbridge will become the sole provider for translation of the company's online content, which includes regulatory, marketing, training, human resources, legal, and corporate communications information. Lionbridge expects this new program to generate approximately $6 million over the term of the contract.

Lionbridge is providing the biotech company an integrated worldwide program for translation and linguistic validation across more than 40 languages. To facilitate an efficient translation process that adheres to strict regulatory compliance requirements, the client's users will access Lionbridge's Freeway® portal technology to streamline project submission, project tracking, collaboration, in-country reviews and reporting. The program will also rely on Logoport®, Lionbridge's Web-architected translation memory technology to facilitate real-time collaboration among all project participants and to assure quality. Because Freeway and Logoport are Web-based, the biotech company can take advantage of the benefits of technology without having to buy, deploy or maintain translation software.

"This new contract is indicative of strengthening demand for Lionbridge services and reflects the value we bring to multinational corporations that need to harmonize processes and manage complex requirements while serving customers worldwide," said Rory Cowan, CEO, Lionbridge. "By integrating our market leading products and services across the enterprise, Lionbridge offers a complete managed service model for multilingual content. As a result, the company gains a flexible and reliable solution for managing global content while increasing quality and consistency."

Separately, the Company announced that it now expects fourth quarter revenue to be at the high-end or above its previously provided revenue guidance range of $98-102 million as a result of new program wins and better than expected revenue volume from certain key customers. The Company will release its fourth quarter and FY 2009 results in early February 2010.

About Lionbridge Life Sciences

Lionbridge Life Sciences specializes in language services for medical device developers, pharmaceutical companies, and CROs, delivering high-quality translation, linguistic validation, and interpretation services in over 150 languages. Life Sciences clients benefit from Lionbridge's highly specialized network of medically trained linguists and professionals operating from solution centers across the world.

About Lionbridge

Lionbridge Technologies, Inc. (Nasdaq: LIOX) is a provider of translation, development and testing solutions. Lionbridge combines global resources with proven program management methodologies to serve as an outsource partner throughout a client's product and content lifecycle - from development to translation, testing and maintenance. Global organizations rely on Lionbridge services to increase international market share, speed adoption of global products and content, and enhance their return on enterprise applications and IT system investments. Based in Waltham, Mass., Lionbridge maintains solution centers in 26 countries and provides services under the Lionbridge and VeriTest brands. To learn more, visit http://www.lionbridge.com.

Lionbridge, Freeway, and Logoport are trademarks or registered trademarks of Lionbridge Technologies, Inc. in the U.S. and throughout the world. All other trademarks are the property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, including those statements relating to expected revenue and revenue growth during the fourth quarter. Lionbridge's actual experience may differ materially from those discussed in the forward-looking statements. Factors that might cause such a difference include the termination of customer contracts prior to the end of their term; Lionbridge's dependence on clients' product releases to generate revenues; the loss of a major client or customer; the size, timing and recognition of revenue from major clients; customer delays or postponements of services; political, economic and business fluctuations in international markets; as well as risks of additional downturns in conditions generally, and in the information technology and software industries specifically, and risks associated with competition and competitive pricing pressures; and Lionbridge's ability to forecast revenue and operating results. For a more detailed description of the risk factors associated with Lionbridge, please refer to Lionbridge's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 3, 2009 and subsequent filings.


    Contact:
    Sara Buda
    Lionbridge
    (781) 434-6190
    sara.buda@lionbridge.com

SOURCE Lionbridge Technologies, Inc.


'/>"/>
SOURCE Lionbridge Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. K-States Biosecurity Research Institute Gives Researchers the Tools Needed to Study Diseases That Cost Pig Producers Hundreds of Millions of Dollars Each Year
2. The Law Offices of Brian D. Witzer Wins 6+ Million Dollar Verdict
3. MMR Seeks Its Slice of the Billion-Dollar Stimulus Pie
4. Intelligroup Secures Multi-Million Dollar COSMOS Implementation with Almac Clinical Services
5. North Carolinas Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs
6. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
7. BSP Raises $2.6 Million Dollars From Private Investors
8. Foamix Signs Term Sheet to Acquire License to Organo-Boron Antifungal Molecules - Will Target the $11 Billion Dollars Fungal Infection Market
9. Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development
10. Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Companys First Annual 2010 Micro Cap Conference
11. YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the ... million people each year. Especially those living in larger cities are affected by air ... one of the most pollution-affected countries globally - decided to take action. , “I ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Club. The event entitled “Stem Cells and Their Regenerative Powers,” was ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., ...
Breaking Biology Technology:
(Date:6/14/2017)...  IBM (NYSE: IBM ) is introducing several innovative ... to developing collaboration between startups and global businesses, taking place ... the event, nine startups will showcase the solutions they have ... France is one ... a 30 percent increase in the number of startups created ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
Breaking Biology News(10 mins):